Free Trial
NASDAQ:NDRA

ENDRA Life Sciences (NDRA) Stock Price, News & Analysis

ENDRA Life Sciences logo
$8.10 +0.10 (+1.25%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$8.08 -0.02 (-0.25%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ENDRA Life Sciences Stock (NASDAQ:NDRA)

Key Stats

Today's Range
$7.78
$8.62
50-Day Range
$3.09
$8.84
52-Week Range
$2.90
$170.63
Volume
296,139 shs
Average Volume
536,923 shs
Market Capitalization
$5.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Consensus Rating
Buy

Company Overview

ENDRA Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

NDRA MarketRank™: 

ENDRA Life Sciences scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ENDRA Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ENDRA Life Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about ENDRA Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for ENDRA Life Sciences are expected to grow in the coming year, from ($47.46) to ($15.38) per share.

  • Price to Book Value per Share Ratio

    ENDRA Life Sciences has a P/B Ratio of 1.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about ENDRA Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    2.10% of the float of ENDRA Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    ENDRA Life Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ENDRA Life Sciences has recently decreased by 6.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ENDRA Life Sciences does not currently pay a dividend.

  • Dividend Growth

    ENDRA Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.10% of the float of ENDRA Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    ENDRA Life Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ENDRA Life Sciences has recently decreased by 6.51%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ENDRA Life Sciences has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for ENDRA Life Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    5 people have searched for NDRA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ENDRA Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.04% of the stock of ENDRA Life Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 1.19% of the stock of ENDRA Life Sciences is held by institutions.

  • Read more about ENDRA Life Sciences' insider trading history.
Receive NDRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

NDRA Stock News Headlines

ENDRA Life Sciences Inc. (NDRA) - Yahoo Finance
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
ENDRA Life Sciences Inc Registered Shs NDRA
See More Headlines

NDRA Stock Analysis - Frequently Asked Questions

ENDRA Life Sciences' stock was trading at $6.26 at the beginning of 2025. Since then, NDRA shares have increased by 29.4% and is now trading at $8.10.

ENDRA Life Sciences Inc. (NASDAQ:NDRA) posted its quarterly earnings results on Monday, March, 31st. The company reported ($9.40) EPS for the quarter, missing analysts' consensus estimates of ($4.10) by $5.30.

Shares of ENDRA Life Sciences reverse split before market open on Tuesday, August 20th 2024.The 1-50 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ENDRA Life Sciences investors own include Bionano Genomics (BNGO), Cocrystal Pharma (COCP), AMC Entertainment (AMC), Plug Power (PLUG), Mustang Bio (MBIO), SNDL (SNDL) and BIOLASE (BIOL).

Company Calendar

Last Earnings
3/31/2025
Today
7/13/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NDRA
CIK
1681682
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$50.00
Low Price Target
$50.00
Potential Upside/Downside
+517.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($172.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.51 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-140.96%
Return on Assets
-106.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.85
Quick Ratio
3.85

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
1.70

Miscellaneous

Outstanding Shares
740,000
Free Float
738,000
Market Cap
$5.99 million
Optionable
Not Optionable
Beta
-0.18
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:NDRA) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners